نتایج جستجو برای: daclatasvir

تعداد نتایج: 714  

Journal: :hepatitis monthly 0
seyed moayed alavian baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran; middle east liver diseases (meld) center, tehran, ir iran; meta-analysis study group for treatment of hepatitis c, iran hepatitis network, tehran, ir iran; baqiyatallah research center for gastroenterology and liver diseases (brcgl), baqiyatallah university of medical sciences, tehran, ir iran. tel: +98-2188945186, fax: +98-2188945188 mohammad saeid rezaee-zavareh middle east liver diseases (meld) center, tehran, ir iran; meta-analysis study group for treatment of hepatitis c, iran hepatitis network, tehran, ir iran; students’ research committee, baqiyatallah university of medical sciences, tehran, ir iran

conclusions among the treatment regimens containing dcv, dcv/sof has the highest svr rate for the treatment of infection with different hcv genotypes in different patient contexts; thus, this regimen shows promise for the treatment of hcv infections. results we found six different regimens containing dcv: dcv/asunaprevir (asv), dcv/asv/beclubavir, dcv/pegylated interferon lambda or alpha/rbv wi...

Journal: :Molecules and Cells 2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has become a global health concern. Various SARS-CoV-2 vaccines have been developed and are being used for vaccination worldwide. However, no therapeutic agents against disease 2019 (COVID-19) so far; therefore, new urgently needed. In the present study, we evaluated several hepatitis C virus direct-acting antivirals as p...

Journal: :Drug Design, Development and Therapy 2014

2014
Sebastian M Lambert David R Langley James A Garnett Richard Angell Katy Hedgethorne Nicholas A Meanwell Steve J Matthews

New direct acting antivirals (DAAs) such as daclatasvir (DCV; BMS-790052), which target NS5A function with picomolar potency, are showing promise in clinical trials. The exact nature of how these compounds have an inhibitory effect on HCV is unknown; however, major resistance mutations appear in the N-terminal region of NS5A that include the amphipathic helix and domain 1. The dimeric symmetry ...

2017
Kazuo Tarao Kouzo Yamada

Oral direct-acting antivirals (DAAs) are the main therapy for hepatitis C virus (HCV)-associated liver disease in Japan. Daclatasvir/asunaprevir is the first agent and sofosbuvir/ledipasvir is the secondary agent for HCV genotype 1b. More recently, ombitasvir/paritaprevir/ritonavir is also recommended as a potent therapy for HCV genotype 1b. Among the adverse events associated with these oral D...

Journal: :Clinical Infectious Diseases 2021

BACKGROUND The combination of sofosbuvir and daclatasvir is a potent, pangenotypic regimen suitable for mass-scale hepatitis C treatment, especially in resource-limited countries where newer, expensive combinations are not available. This has been widely tested on genotype 4. However, Phase III trials this other genotypes have cost prohibitive. With the introduction generic, low-cost daclatasvi...

Journal: :QJM: An International Journal of Medicine 2021

Abstract Purpose This study aims to evaluate the effect of oral (sofosbuvir / daclatasvir) Combination on macular and choroidal thickness Egyptian patients with chronic hepatitis C virus infection using Optical Coherence Tomography (OCT) Methods was conducted 30 subjects recruited from Viral Hepatitis Treatment Research Centre examined at Ophthalmology Out Patients Clinics, Ain Shams University...

Journal: :Pro-fono : revista de atualizacao cientifica 2007
Karla Maria Ibrahim da Freiria Elias Maria Francisca Colella Dos Santos Sylvia Maria Ciasca Maria Valeriana Leme de Moura-Ribeiro

BACKGROUND cerebrovascular disease (CVD) during childhood is a rare condition; its short, medium and long-term characteristics deserve further investigation. The application of behavioral techniques may improve clinical characterization, thus rendering more efficient therapeutic planning and control. AIM to describe the audiological manifestations in a child with CVD in two distinct moments o...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید